Wall St. Brief: Barclays Chairman RESIGNS, Bristol-Myers Makes HUGE Acquisition
Barclays (NYSE:BCS) Chairman Marcus Agius has resigned in light of the Libor scandal; upon exiting, he said, “the buck stops with me.” But the pressure continues for the bank’s CEO, Bob Diamond, to also resign. Britain’s prime minister David Cameron has referred to the scandal as “extremely serious” and said management had “some big questions to answer.”
Bristol-Myers Squibb (NYSE:BMY) and AstraZeneca (NYSE:AZN) have agreed to purchase the diabetes drug maker Amylin (NASDAQ:AMLN) for $31 per share; this equals a 10 percent premium to Friday’s close. The deal’s size is $7 billion and $3.4 billion will come from AstraZeneca as it broadens its diabetes collaboration with Bristol-Myers. In premarket trading, Amylin shares were up 8.5 percent.
Micron Technology (NASDAQ:MU) will acquire Elpida Memory for about $750 million. Under the deal’s terms, Micron will also pay the creditors of the bankrupt Japanese company $1.75 billion in annual payments until 2019.
Dell (NASDAQ:DELL) could announce on Monday that it will buy Quest Software (NASDAQ:QSFT), reported the Wall Street Journal. The deal’s final price hasn’t been disclosed but Dell had reportedly offered $2.3 billion or $27.50 per share last week.
Amazon Web Services (NASDAQ:AMZN) underwent a large outage over the weekend thanks to storms on the East Coast. It affected Netflix (NASDAQ:NFLX), Instagram, Pinterest, and other clients. This was the second time in June that AWS went down and combined with Salesforce.com (NYSE:CRM)’s Thurday outage, it brings to light enterprises’ concerns with cloud services.
Don’t Miss: The iPad Goes CHROME.